Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001069530-19-000070)

Filing Details

Accession Number:: 0001069530-19-000070
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-12-26 16:00:21
Reporting Period:: 2019-12-18

Accepted Time:: 2019-12-26 16:00:21
Original Submission Date:: 2019-12-20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069530	Cassava Sciences Inc	SAVA	Pharmaceutical Preparations (2834)	911911336

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1133806	Remi Barbier	C/O Cassava Sciences, Inc. 7801 N. Capital Of Texas Hwy.; Suite 260 Austin TX 78731	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-18	2,599	$1.65	958,855	No	4	P	Indirect	Purchase by spouse of reporting person

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Purchase by spouse of reporting person

Footnotes

In a Form 4 filed on December 20, 2019 (the "Form 4"), the reporting person reported 2,599 shares as the "Amount of Securities Beneficially Owned Following Reported Transaction." This amendment to the Form 4 is being filed to reflect 958,855 as the correct number of shares of stock beneficially owned by the reporting person following the reported transaction.